ArticleEndocrine, metabolic & immune disorders drug targets2024

Eicosapentaenoic Acid: between Cardiovascular Benefits and the Risk of Atrial Fibrillation.

Filippo Egalini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.